Roswell Park Cancer Institute
Agilent Licenses Roswell Park-Developed Blood Cancer Test
The assay is intended to aid oncologists in diagnosing and directing appropriate treatment for patients with a variety of hematologic cancers.
Breast Cancer Outcomes Show Ties to Neighborhood Income in New Study
In estrogen receptor-positive breast cancer patients, lower income appeared to track with higher tumor expression-based recurrence scores, and shorter survival in the low-risk RS group.
People in the News at Personalis, Roche, Massive Bio, SeqLL, More
Executive appointments, promotions, and departures in omics and molecular diagnostics for the week of Dec. 12, 2022.
NCI Grants $1.9M to Roswell Park to Study Molecular Race-Based Breast Cancer Disparities
The grant will fund an investigation into long noncoding RNA and the role it plays in differing prognoses between Black and white breast cancer patients.
Roswell Park, Catholic Health, University of Buffalo Partner on Coronavirus Sequencing Study
The study, which is being supported by Thermo Fisher Scientific, aims to identify genetic biomarkers that can predict patients likely to develop severe disease.